Gregory Lazar

Person

Pacifica, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Fusion proteins
- Patent number 12,059,452
- Issue date Aug 13, 2024
- Eli Lilly and Company
- David Bruce Baldwin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fc variants with altered binding to FcRn
- Patent number 11,932,685
- Issue date Mar 19, 2024
- Xencor, Inc.
- Aaron Keith Chamberlain
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Optimized Fc variants
- Patent number 11,820,830
- Issue date Nov 21, 2023
- Xencor, Inc.
- Gregory Lazar
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Optimized antibodies that target CD19
- Patent number 11,618,788
- Issue date Apr 4, 2023
- Xencor, Inc.
- Matthew J. Bernett
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
FLT3 ligand fusion proteins and methods of use
- Patent number 11,542,308
- Issue date Jan 3, 2023
- Genentech, Inc.
- Yichin Liu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for inhibiting CD32B expressing cells
- Patent number 11,447,552
- Issue date Sep 20, 2022
- Xencor, Inc.
- Seung Yup Chu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for inhibiting CD32B expressing cells
- Patent number 11,434,295
- Issue date Sep 6, 2022
- Xencor, Inc.
- Seung Yup Chu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterodimeric Fc variants
- Patent number 11,401,348
- Issue date Aug 2, 2022
- Xencor, Inc.
- Gregory Lazar
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CTLA4-IG immunoadhesins
- Patent number 11,352,412
- Issue date Jun 7, 2022
- Xencor, Inc.
- Gregory A. Lazar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CTLA4-Ig immunoadhesins
- Patent number 11,254,727
- Issue date Feb 22, 2022
- Xencor, Inc.
- Gregory A. Lazar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fusion proteins and methods of use
- Patent number 11,253,574
- Issue date Feb 22, 2022
- Eli Lilly and Company
- David Bruce Baldwin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fc variants with altered binding to FcRn
- Patent number 11,198,739
- Issue date Dec 14, 2021
- Xencor, Inc.
- Aaron Keith Chamberlain
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-transferrin receptor antibodies and methods of use
- Patent number 11,098,129
- Issue date Aug 24, 2021
- Genentech, Inc.
- Yin Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Multivalent and multiepitopic antibodies having agonistic activity...
- Patent number 11,046,776
- Issue date Jun 29, 2021
- Genentech, Inc.
- Greg Lazar
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-transferrin receptor / anti-BACE1 multispecific antibodies and...
- Patent number 11,008,403
- Issue date May 18, 2021
- Genentech, Inc.
- Yichin Liu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antigen binding complex having agonistic activity and methods of use
- Patent number 10,865,248
- Issue date Dec 15, 2020
- Genentech, Inc.
- Greg Lazar
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-transferrin receptor antibodies and methods of use
- Patent number 10,808,036
- Issue date Oct 20, 2020
- Genentech, Inc.
- Yin Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fusion proteins
- Patent number 10,709,766
- Issue date Jul 14, 2020
- Eli Lilly and Company
- David Bruce Baldwin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Optimized antibodies that target CD19
- Patent number 10,626,182
- Issue date Apr 21, 2020
- Xencor, Inc.
- Matthew J. Bernett
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fc variants with increased affinity for FcγRIIc
- Patent number 10,584,176
- Issue date Mar 10, 2020
- Xencor, Inc.
- Gregory Lazar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-transferrin receptor antibodies and methods of use
- Patent number 10,508,151
- Issue date Dec 17, 2019
- Genentech, Inc.
- Yin Zhang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fc variants with altered binding to FcRn
- Patent number 10,336,818
- Issue date Jul 2, 2019
- Xencor, Inc.
- Aaron Keith Chamberlain
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Optimized Fc variants and methods for their generation
- Patent number 10,183,999
- Issue date Jan 22, 2019
- Xencor, Inc.
- Gregory Alan Lazar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Optimized Fc variants and methods for their generation
- Patent number 10,184,000
- Issue date Jan 22, 2019
- Xencor, Inc.
- Gregory Alan Lazar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CTLA4-Ig immunoadhesins
- Patent number 10,155,800
- Issue date Dec 18, 2018
- Xencor, Inc.
- Gregory A. Lazar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-glypican-3 antibody
- Patent number 10,118,959
- Issue date Nov 6, 2018
- CHUGAI SEIYAKU KABUSHIKI KAISHA
- Gregory Alan Lazar
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Fc variants with increased affinity for FcyRIIc
- Patent number 10,113,001
- Issue date Oct 30, 2018
- Xencor, Inc.
- Gregory Lazar
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods and compositions for inhibiting CD32B expressing cells
- Patent number 9,914,778
- Issue date Mar 13, 2018
- Xencor, Inc.
- Seung Yup Chu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods and compositions for inhibiting CD32b expressing cells
- Patent number 9,902,773
- Issue date Feb 27, 2018
- Xencor, Inc.
- Seung Yup Chu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Fusion proteins
- Patent number 9,855,318
- Issue date Jan 2, 2018
- Eli Lilly and Company
- David Bruce Baldwin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
Fc VARIANTS WITH ALTERED BINDING TO FcRn
- Publication number 20240327508
- Publication date Oct 3, 2024
- Xencor, Inc.
- Aaron Keith Chamberlain
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Fc VARIANTS WITH ALTERED BINDING TO FcRn
- Publication number 20240239879
- Publication date Jul 18, 2024
- Xencor, Inc.
- Aaron Keith Chamberlain
- Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMA...
Information Patent Application
OPTIMIZED Fc VARIANTS
- Publication number 20240026023
- Publication date Jan 25, 2024
- Xencor, Inc.
- Gregory Lazar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
OPTIMIZED ANTIBODIES THAT TARGET CD19
- Publication number 20230340144
- Publication date Oct 26, 2023
- Xencor, Inc.
- Matthew J. Bernett
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FLT3 LIGAND FUSION PROTEINS AND METHODS OF USE
- Publication number 20230279067
- Publication date Sep 7, 2023
- Genentech, Inc.
- Yichin LIU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS IN I...
- Publication number 20230227560
- Publication date Jul 20, 2023
- Xencor, Inc.
- Seung Yup Chu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Fc VARIANTS THAT IMPROVE FcRn BINDING AND/OR INCREASE ANTIBODY HALF...
- Publication number 20230056900
- Publication date Feb 23, 2023
- Xencor, Inc.
- Gregory Alan Lazar
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL CTLA4-IG IMMUNOADHESINS
- Publication number 20220348634
- Publication date Nov 3, 2022
- Xencor, Inc.
- Gregory A. Lazar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Fc VARIANTS THAT IMPROVE FcRn BINDING AND/OR INCREASE ANTIBODY HALF...
- Publication number 20220324946
- Publication date Oct 13, 2022
- Xencor, Inc.
- Gregory Alan Lazar
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FLT3 LIGAND FUSION PROTEINS AND METHODS OF USE
- Publication number 20220289803
- Publication date Sep 15, 2022
- Genentech, Inc.
- Yichin LIU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Fc VARIANTS WITH ALTERED BINDING TO FcRn
- Publication number 20220281964
- Publication date Sep 8, 2022
- Xencor, Inc.
- Aaron Keith Chamberlain
- C07 - ORGANIC CHEMISTRY
Information Patent Application
FUSION PROTEINS
- Publication number 20220211818
- Publication date Jul 7, 2022
- Eli Lilly and Company
- David Bruce Baldwin
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Fc VARIANTS WITH ALTERED BINDING TO FcRn
- Publication number 20220112307
- Publication date Apr 14, 2022
- Xencor, Inc.
- Aaron Keith Chamberlain
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MULTIVALENT AND MULTIEPITOPIC ANTIBODIES HAVING AGONISTIC ACTIVITY...
- Publication number 20220064315
- Publication date Mar 3, 2022
- Genentech, Inc.
- Greg LAZAR
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MODIFIED ANTIBODY FCS AND METHODS OF USE
- Publication number 20220033520
- Publication date Feb 3, 2022
- Genentech, Inc.
- Gregory A. Lazar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS
- Publication number 20210395363
- Publication date Dec 23, 2021
- Xencor, Inc.
- Seung Yup Chu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Fc VARIANTS WITH ALTERED BINDING TO FcRn
- Publication number 20210277095
- Publication date Sep 9, 2021
- Xencor, Inc.
- Aaron Keith Chamberlain
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NOVEL CTLA4-IG IMMUNOADHESINS
- Publication number 20210230250
- Publication date Jul 29, 2021
- Gregory A. Lazar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Fc VARIANTS THAT IMPROVE FcRn BINDING AND/OR INCREASE ANTIBODY HALF...
- Publication number 20210179693
- Publication date Jun 17, 2021
- Xencor, Inc.
- Gregory Alan Lazar
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Fc VARIANTS THAT IMPROVE FcRn BINDING AND/OR INCREASE ANTIBODY HALF...
- Publication number 20210163577
- Publication date Jun 3, 2021
- Xencor, Inc.
- Gregory Alan Lazar
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIGEN BINDING COMPLEX HAVING AGONISTIC ACTIVITY AND METHODS OF USE
- Publication number 20210147562
- Publication date May 20, 2021
- Genentech, Inc.
- Gregory LAZAR
- C07 - ORGANIC CHEMISTRY
Information Patent Application
OPTIMIZED Fc VARIANTS
- Publication number 20210139600
- Publication date May 13, 2021
- Xencor, Inc.
- Gregory Lazar
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Fc VARIANTS WITH ALTERED BINDING TO FcRn
- Publication number 20210115147
- Publication date Apr 22, 2021
- Xencor, Inc.
- Aaron Keith Chamberlain
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Fc VARIANTS WITH ALTERED BINDING TO FcRn
- Publication number 20210115118
- Publication date Apr 22, 2021
- Xencor, Inc.
- Aaron Keith Chamberlain
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-TRANSFERRIN RECEPTOR ANTIBODIES AND METHODS OF USE
- Publication number 20210087288
- Publication date Mar 25, 2021
- Genentech, Inc.
- Yin Zhang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS
- Publication number 20210009689
- Publication date Jan 14, 2021
- Xencor, Inc.
- Seung Yup Chu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS
- Publication number 20210009690
- Publication date Jan 14, 2021
- Xencor, Inc.
- Seung Yup Chu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FUSION PROTEINS
- Publication number 20200390865
- Publication date Dec 17, 2020
- Eli Lilly and Company
- David Bruce Baldwin
- C07 - ORGANIC CHEMISTRY
Information Patent Application
OPTIMIZED ANTIBODIES THAT TARGET CD19
- Publication number 20200317804
- Publication date Oct 8, 2020
- Xencor, Inc.
- Matthew J. Bernett
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Fc VARIANTS WITH ALTERED BINDING TO FcRn
- Publication number 20200262899
- Publication date Aug 20, 2020
- Xencor, Inc.
- Aaron Keith Chamberlain
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Gregory Lazar

Person

Patents Grantslast 30 patents

Fusion proteins

Fc variants with altered binding to FcRn

Optimized Fc variants

Optimized antibodies that target CD19

FLT3 ligand fusion proteins and methods of use

Methods and compositions for inhibiting CD32B expressing cells

Methods and compositions for inhibiting CD32B expressing cells

Heterodimeric Fc variants

CTLA4-IG immunoadhesins

CTLA4-Ig immunoadhesins

Fusion proteins and methods of use

Fc variants with altered binding to FcRn

Anti-transferrin receptor antibodies and methods of use

Multivalent and multiepitopic antibodies having agonistic activity...

Anti-transferrin receptor / anti-BACE1 multispecific antibodies and...

Antigen binding complex having agonistic activity and methods of use

Anti-transferrin receptor antibodies and methods of use

Fusion proteins

Optimized antibodies that target CD19

Fc variants with increased affinity for FcγRIIc

Anti-transferrin receptor antibodies and methods of use

Fc variants with altered binding to FcRn

Optimized Fc variants and methods for their generation

Optimized Fc variants and methods for their generation

CTLA4-Ig immunoadhesins

Anti-glypican-3 antibody

Fc variants with increased affinity for FcyRIIc

Methods and compositions for inhibiting CD32B expressing cells

Methods and compositions for inhibiting CD32b expressing cells

Fusion proteins

Patents Applicationslast 30 patents

Fc VARIANTS WITH ALTERED BINDING TO FcRn

Fc VARIANTS WITH ALTERED BINDING TO FcRn

OPTIMIZED Fc VARIANTS

OPTIMIZED ANTIBODIES THAT TARGET CD19

FLT3 LIGAND FUSION PROTEINS AND METHODS OF USE

METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS IN I...

Fc VARIANTS THAT IMPROVE FcRn BINDING AND/OR INCREASE ANTIBODY HALF...

NOVEL CTLA4-IG IMMUNOADHESINS

Fc VARIANTS THAT IMPROVE FcRn BINDING AND/OR INCREASE ANTIBODY HALF...

FLT3 LIGAND FUSION PROTEINS AND METHODS OF USE

Fc VARIANTS WITH ALTERED BINDING TO FcRn

FUSION PROTEINS

Fc VARIANTS WITH ALTERED BINDING TO FcRn

MULTIVALENT AND MULTIEPITOPIC ANTIBODIES HAVING AGONISTIC ACTIVITY...

MODIFIED ANTIBODY FCS AND METHODS OF USE

METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS

Fc VARIANTS WITH ALTERED BINDING TO FcRn

NOVEL CTLA4-IG IMMUNOADHESINS

Fc VARIANTS THAT IMPROVE FcRn BINDING AND/OR INCREASE ANTIBODY HALF...

Fc VARIANTS THAT IMPROVE FcRn BINDING AND/OR INCREASE ANTIBODY HALF...

ANTIGEN BINDING COMPLEX HAVING AGONISTIC ACTIVITY AND METHODS OF USE

OPTIMIZED Fc VARIANTS

Fc VARIANTS WITH ALTERED BINDING TO FcRn

Fc VARIANTS WITH ALTERED BINDING TO FcRn

ANTI-TRANSFERRIN RECEPTOR ANTIBODIES AND METHODS OF USE

METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS

METHODS AND COMPOSITIONS FOR INHIBITING CD32B EXPRESSING CELLS

FUSION PROTEINS

OPTIMIZED ANTIBODIES THAT TARGET CD19

Fc VARIANTS WITH ALTERED BINDING TO FcRn